Open AccessThe use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study
Author(s) -
Deniz Can Güven,
HASAN ÇAĞRI YILDIRIM,
Enes Erul,
Taha Koray Şahin,
İBRAHİM YAHYA ÇAKIR,
Oktay Halit Aktepe,
Neyran Kertmen,
Ömer Dızdar,
Sercan Aksoy
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2103-117
Subject(s) - fulvestrant , medicine , oncology , cohort , breast cancer , chemotherapy , cancer , metastatic breast cancer , tamoxifen
We aimed to evaluate the efficacy of fulvestrant and affecting clinical factors, including the optimal sequencing of fulvestrant and chemotherapy in a real-life cohort.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom